053950 — Kyung Nam Pharm Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Market Cap
KR₩37bn
Enterprise Value
KR₩64bn
Revenue
KR₩68bn

Annual balance sheet for Kyung Nam Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	23,937	27,495	23,248	45,478	35,013
Net Total Accounts Receivable
Net Total Receivables	14,882	19,692	16,451	13,945	19,443
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	52,105	57,639	54,920	77,329	71,198
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	15,827	32,227	33,852	31,235	46,710
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	74,460	126,655	125,307	138,269	166,609
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	10,676	38,605	25,411	43,887	66,933
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	13,266	69,291	52,778	44,498	87,248
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	61,194	57,364	72,529	93,771	79,362
Total Liabilities & Shareholders' Equity	74,460	126,655	125,307	138,269	166,609
Total Common Shares Outstanding